Total medical devices industry cross border M&A deals worth $472.5m were announced globally in February 2022, led by Dreamtech’s $227.57m acquisition of 9.1% stake in Cardiac Insight, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 20.3% over the previous month of $592.62m and a drop of 71.5% when compared with the last 12-month average, which stood at $1.66bn.

Comparing cross border M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $261.57m. At the country level, the US topped the list in terms of deal value at $261.57m.

In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then Asia-Pacific.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top country in terms of cross border M&A deals activity in February 2022 was the US with seven deals, followed by the Denmark with three and Germany with three.

In 2022, as of February, medical devices cross border M&A deals worth $1.07bn were announced globally, marking an increase of 42.8% year on year.

medical devices industry cross border M&A deals in February 2022: Top deals

The top three cross border M&A deals accounted for 99.7% of the overall value during February 2022.

The combined value of the top three medical devices cross border M&A deals stood at $471.52m, against the overall value of $472.5m recorded for the month.

The top three medical devices industry cross border M&A deals of February 2022 tracked by GlobalData were:

1) Dreamtech $227.57m acquisition deal for 9.1% stake in Cardiac Insight

2) The $210m private equity deal with Micro Life Sciences by South Elm Investments B V

3) Fagron $34m acquisition deal with Letco Medical